These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32733104)

  • 1. Emerging role of NET inhibitors in cardiovascular diseases.
    Jayaseelan VP; Paramasivam A
    Hypertens Res; 2020 Dec; 43(12):1459-1461. PubMed ID: 32733104
    [No Abstract]   [Full Text] [Related]  

  • 2. Emerging Cardiovascular Therapeutics. Cambridge, MA, USA, June 10-11, 2003.
    Zavoico GB
    Cardiovasc Drug Rev; 2003; 21(3):246-53. PubMed ID: 14582482
    [No Abstract]   [Full Text] [Related]  

  • 3. Selected mucolytic, anti-inflammatory and cardiovascular drugs change the ability of neutrophils to form extracellular traps (NETs).
    Zawrotniak M; Kozik A; Rapala-Kozik M
    Acta Biochim Pol; 2015; 62(3):465-73. PubMed ID: 26291043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abstracts of the 10th International Congress on Cardiovascular Pharmacotherapy. Kyoto, Japan, 27-31 March 2001.
    Cardiovasc Drugs Ther; 2001 Mar; 15 Suppl 1():1-166. PubMed ID: 11501560
    [No Abstract]   [Full Text] [Related]  

  • 5. The importance of drug discovery for treatment of cardiovascular diseases.
    Kennedy C
    Future Med Chem; 2013 Mar; 5(4):355-7. PubMed ID: 23495678
    [No Abstract]   [Full Text] [Related]  

  • 6. Abstracts of the 11th International Congress on Cardiovascular Pharmacotherapy. Montreal, Canada, 18-21 May 2002.
    Cardiovasc Drugs Ther; 2002; 16 Suppl 1():5-116. PubMed ID: 12108434
    [No Abstract]   [Full Text] [Related]  

  • 7. Gp IIb/IIIa antagonists. Summary and table.
    Coleman SG; Duff R
    Drugs R D; 1999 May; 1(5):371-3. PubMed ID: 10566066
    [No Abstract]   [Full Text] [Related]  

  • 8. Abstracts of the 13th International Congress on Cardiovascular Pharmacotherapy. November 29-December 2, 2007. Antalya, Turkey.
    Remme WJ
    Cardiovasc Drugs Ther; 2007 Nov; 21 Suppl 1(1):S6-43. PubMed ID: 17963033
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular pharmacology in the post-blockbuster era.
    Brandes RP
    Curr Opin Pharmacol; 2010 Apr; 10(2):109-10. PubMed ID: 20202904
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular therapeutics.
    Shakur R; Cockrum E; Scott D
    Br J Hosp Med (Lond); 2008 Sep; 69(9):M136-40. PubMed ID: 18819300
    [No Abstract]   [Full Text] [Related]  

  • 11. Achieving current goals in prevention and treatment of vascular disease: an update.
    Catapano AL; Elisaf MS; Florentin M; Mikhailidis DP; Kostapanos MS
    Curr Pharm Des; 2013; 19(21):3749-52. PubMed ID: 23286439
    [No Abstract]   [Full Text] [Related]  

  • 12. The newest critical care drugs.
    Chase SL
    RN; 1999 May; 62(5):34-9; quiz 40. PubMed ID: 10418524
    [No Abstract]   [Full Text] [Related]  

  • 13. American Heart Association--Scientific Sessions 2008--Studies with investigative drugs--Part 2.
    Kirkham K
    IDrugs; 2009 Jan; 12(1):7-9. PubMed ID: 19127495
    [No Abstract]   [Full Text] [Related]  

  • 14. American Heart Association--Scientific Sessions 2008--Studies with investigative drugs--Part 1.
    Kirkham K
    IDrugs; 2009 Jan; 12(1):5-6. PubMed ID: 19127494
    [No Abstract]   [Full Text] [Related]  

  • 15. [Can endothelium be treated with drugs?].
    Fyhrquist F
    Duodecim; 1993; 109(20):1841-7. PubMed ID: 7737007
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacogenetics--new perspectives in the treatment of cardiovascular diseases].
    Dzida G
    Kardiol Pol; 2004 Mar; 60(3):304-8. PubMed ID: 15156230
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular drugs: reason for promise and vigilance.
    Miller CA
    Geriatr Nurs; 2002; 23(3):171-2. PubMed ID: 12075284
    [No Abstract]   [Full Text] [Related]  

  • 18. Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC.
    Rosano GM; Lewis B; Agewall S; Wassmann S; Vitale C; Schmidt H; Drexel H; Patak A; Torp-Pedersen C; Kjeldsen KP; Tamargo J
    Eur Heart J; 2015 Oct; 36(40):2677-80. PubMed ID: 25948737
    [No Abstract]   [Full Text] [Related]  

  • 19. 8th International Symposium on Cardiovascular Pharmacotherapy. Amsterdam, The Netherlands. March 28 April 1, 1999. Abstracts.
    Cardiovasc Drugs Ther; 1999 Mar; 13(1):1-86. PubMed ID: 10405623
    [No Abstract]   [Full Text] [Related]  

  • 20. Investigation of vascular mechanisms: bridging the gap between basic research and clinical trials.
    Collier J; Vallance P
    Trends Pharmacol Sci; 1993 Jul; 14(7):257-8. PubMed ID: 8212320
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.